Drug Type Peptides |
Synonyms- |
Target |
Action antagonists |
Mechanism melanocortin receptor antagonists(黑皮质素受体拮抗剂) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cachexia | Preclinical | United States | 01 Sep 2025 |





